SCHEMBL4184556

SCHEMBL4184556

CCNc1ccccc1C(=O)CC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
RAB9A P51151 2/20 0.46
AGTR1 P30556 2/20 0.46
FABP4 P15090 1/20 0.46
GLA P06280 1/20 0.45
ALDH1A1 P00352 4/20 0.44
NPC1 O15118 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
JAK2 O60674 2/20 0.44
JAK1 P23458 2/20 0.44
ELANE P08246 1/20 0.44
PRTN3 P24158 1/20 0.44
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
GAA P10253 1/20 0.42
IDO1 P14902 1/20 0.42
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2955045 0.98 KDM4E (0.45) KDM4ERAB9AAGTR1FABP4GLA
SCHEMBL20274413 0.85 KDM4E (0.50) KDM4ERAB9AAGTR1GLAALDH1A1
SCHEMBL2920235 0.85 KDM4E (0.44) KDM4ERAB9AAGTR1GLAALDH1A1
SCHEMBL27611476 0.85 KDM4E (0.44) KDM4ERAB9AAGTR1GLAALDH1A1
SCHEMBL2001238 0.84 FABP4 (0.48) KDM4ERAB9AAGTR1FABP4GLA
SCHEMBL605325 0.82 KDM4E (0.58) KDM4ERAB9AFABP4ALDH1A1NPC1
SCHEMBL7959032 0.82 ALDH1A1 (0.45) KDM4ERAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL184136 0.82 ALDH1A1 (0.62) KDM4ERAB9AAGTR1FABP4ALDH1A1
SCHEMBL6088062 0.82 JAK2 (0.48) KDM4ERAB9AAGTR1FABP4GLA
SCHEMBL4761103 0.82 TSHR (0.53) KDM4EGLAALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741934-B2 Inhibitors of ion channels PFIZER LIMITED (GB) 2014-06-03 US disclosed
US-20130072471-A1 Inhibitors of Ion Channels MARRON BRIAN EDWARD (US) 2013-03-21 US disclosed
US-8357711-B2 Heterocyclic sulfonamides as inhibitors of ion channels PFIZER LIMITED (GB) 2013-01-22 US disclosed
US-20090143358-A1 INHIBITORS OF ION CHANNELS ICAGEN, INC. (US) 2009-06-04 US disclosed
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072471-A1 Inhibitors of Ion Channels TRPV1, TRPV5, TRPA1 KDM4E 1973/4885RAB9A 2301/4885AGTR1 1854/4885
US-20090143358-A1 INHIBITORS OF ION CHANNELS TRPV1, TRPV5, TRPA1 KDM4E 1973/4885RAB9A 2301/4885AGTR1 1854/4885
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KDM4E 1333/4885RAB9A 3734/4885AGTR1 779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.